Jian Bin, Li Zhongfu, Xiao Dachun, He Gan, Bai Lian, Yang Qiang
Department of Gastrointestinal surgery, Yongchuan Hospital, Chongqing Medical University, 439 Xuanhua Road, Chongqing, 402160, China.
Tumour Biol. 2016 Jul;37(7):8941-9. doi: 10.1007/s13277-015-4727-x. Epub 2016 Jan 11.
In this study, we investigated the functional mechanisms of microRNA-193-3p (miR-193-3p) in human gastric cancer. Quantitative RT-PCR (qRT-PCR) was used to assess whether miR-193-3p was aberrantly expressed in gastric cancer cells and clinical samples from gastric cancer patients. Gastric cancer cell line AGS and MKN-45 cells were stably transduced with lentivirus to downregulate endogenous miR-193-3p. The modulation of miR-193-3p downregulation on gastric cancer proliferation, migration, chemo-drug responses, and tumor explant were assessed by MTT, wound-healing, 5-FU chemoresistance and in vivo tumorigenicity assays, respectively. Downstream target of miR-193-3p, phosphatase and tensin homolog (PTEN) in gastric cancer, was assessed by dual-luciferase reporter assay, qRT-PCR, and western blot. PTEN was knocked down by siRNA in AGS and MKN-45 cells to assess its direct impact on miR-193-3p modulation in gastric cancer. MiR-193-3p was aberrantly upregulated in both gastric cell lines and human gastric tumors. In AGS and MKN-45 cells, miR-193-3p downregulation reduced cancer proliferation, migration and 5-FU chemoresistance in vitro, and tumorigenicity in vivo. PTEN was confirmed to be targeted by miR-193-3p in gastric cancer. PTEN inhibition in AGS and MKN-45 cells directly reversed the anti-tumor modulations of miR-193-3p downregulation on gastric cancer proliferation, migration, and 5-FU chemoresistance. We presented clear evidence showing miR-193-3p played critical role in regulating human gastric cancer through direct targeting on PTEN gene.
在本研究中,我们探究了微小RNA-193-3p(miR-193-3p)在人类胃癌中的功能机制。采用定量逆转录聚合酶链反应(qRT-PCR)评估miR-193-3p在胃癌细胞和胃癌患者临床样本中是否异常表达。用慢病毒稳定转导胃癌细胞系AGS和MKN-45细胞以下调内源性miR-193-3p。分别通过MTT法、伤口愈合实验、5-氟尿嘧啶(5-FU)化疗耐药实验和体内成瘤实验评估miR-193-3p下调对胃癌增殖、迁移、化疗药物反应及肿瘤外植体的影响。通过双荧光素酶报告基因实验、qRT-PCR和蛋白质免疫印迹法评估miR-193-3p在胃癌中的下游靶点——磷酸酶和张力蛋白同源物(PTEN)。在AGS和MKN-45细胞中用小干扰RNA(siRNA)敲低PTEN以评估其对胃癌中miR-193-3p调控的直接影响。miR-193-3p在胃癌细胞系和人类胃肿瘤中均异常上调。在AGS和MKN-45细胞中,miR-193-3p下调可降低体外癌细胞增殖、迁移及5-FU化疗耐药性,并降低体内成瘤性。证实PTEN是miR-193-3p在胃癌中的靶点。在AGS和MKN-45细胞中抑制PTEN可直接逆转miR-193-3p下调对胃癌增殖、迁移及5-FU化疗耐药性的抗肿瘤调控作用。我们提供了明确证据表明miR-193-3p通过直接靶向PTEN基因在调控人类胃癌中发挥关键作用。